Moderna, Inc. Common Stock
Market cap $63.1B
$155.61
MRNA
$155.61
-0.03% today
Buy with €1M virtual cash · No real money
Moderna, Inc. Common Stock (MRNA) is a publicly traded company listed on the XNAS. As of September 18, 2026, Invest's signal rates MRNA a Buy, with the stock up 522% over the past year. You can practice trading MRNA risk-free with €1,000,000 in virtual cash.
Key stats
As of September 18, 2026
Market Cap
$63.1B
Volume
6.5M
52-wk High
$176.66
52-wk Low
$22.28
Day High
$159.79
Day Low
$153.80
Revenue (TTM)
$2.2B
EPS (TTM)
$-7.99
Performance
1M
-10.8%
6M
+197.1%
1Y
+522.4%
Invest signal · MRNA
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
MRNA overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev -62.7%Revenue
$145MEPS (diluted)
$-1.97 per shareLatest MRNA news
Zacks Investment Ideas feature highlights: NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver
Zacks Investment Research · 8h ago
Is Cancer the Turnaround Moderna Has Been Looking for Post-COVID?
Zacks Investment Research · 3d ago
Moderna (MRNA) Ascends While Market Falls: Some Facts to Note
Zacks Investment Research · 3d ago
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
Zacks Investment Research · Sep 11
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell?
Zacks Investment Research · Sep 8
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026.
Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Employees
4,700
30-Day Win Rate · MRNA
11 days
13 days
Last 24 sessions
How to practice trading MRNA
- 1
Use the MRNA buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top MRNA traders on Invest
Full leaderboardFrequently asked questions
Is MRNA a good stock to buy right now?
As of September 18, 2026, Invest's signal rates MRNA a Buy, based on its price trend, valuation, and fundamentals, with the stock up 522% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading MRNA risk-free first.
What is Moderna, Inc. Common Stock's (MRNA) market cap?
Moderna, Inc. Common Stock has a market capitalization of approximately $63.1B, on trailing-twelve-month revenue of about $2.2B.
How has MRNA stock performed?
MRNA is up 522% over the past year and up 197% over six months. Its 52-week range runs roughly from $22.28 to $176.66. Past performance doesn't predict future results.
How can I practice trading MRNA for free?
On Invest you get €1,000,000 in virtual cash and can buy MRNA at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare MRNA with peers